Z-2322-2025 Class II Ongoing

Recalled by Beckman Coulter, Inc. — Chaska, MN

FDA device recall Z-2322-2025 was initiated by Beckman Coulter, Inc. on Jul 10, 2025 and is designated Class II. Reason for recall: Access Thyroglobulin reagent lot 439163 may generate erroneously high patient results. Falsely increased Access Thyroglobulin results may lead a physician to pursue unnecessary diagnostic imaging… The recall status is ongoing. Affected quantity: 453 units.

Recall details

Product Type
Devices
Report Date
Aug 20, 2025
Initiation Date
Jul 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
453 units

Product description

Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860

Reason for recall

Access Thyroglobulin reagent lot 439163 may generate erroneously high patient results. Falsely increased Access Thyroglobulin results may lead a physician to pursue unnecessary diagnostic imaging studies and/or inappropriate therapy adjustments in patients being monitored for residual or recurrent thyroid cancer.

Distribution pattern

Worldwide - US Nationwide and the countries of Brazil, Canada, Georgia, Italy, Malaysia, Mexico, Philippines, Spain.

Code information

UDI-DI: 15099590227173; Lot Number: 439163

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2322-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2322-2025. Report a data issue: hello@regdatalab.com.